These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 8608520)

  • 21. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
    Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
    Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
    Sanz MA; Bermúdez A; Rovira M; Besalduch J; Pascual MJ; Nocea G; Sanz-Rodríguez C;
    Curr Med Res Opin; 2005 May; 21(5):645-55. PubMed ID: 15969864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy].
    Kattan J; Droz JP; Culine S; Ribrag V; Boutan-Laroze A; Andremont A
    Bull Cancer; 1992; 79(7):705-12. PubMed ID: 1467596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer.
    Riikonen P
    Pediatr Infect Dis J; 1991 Dec; 10(12):918-23. PubMed ID: 1766707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients.
    Rolston KV; Berkey P; Bodey GP; Anaissie EJ; Khardori NM; Joshi JH; Keating MJ; Holmes FA; Cabanillas FF; Elting L
    Arch Intern Med; 1992 Feb; 152(2):283-91. PubMed ID: 1739355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study.
    Kelsey SM; Shaw E; Newland AC
    J Chemother; 1992 Apr; 4(2):107-13. PubMed ID: 1629747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of imipenem versus cefuroxime plus tobramycin as empirical therapy for febrile granulocytopenic patients and efficacy of vancomycin and aztreonam in case of failure.
    Erjavec Z; de Vries-Hospers HG; van Kamp H; van der Waaij D; Halie MR; Daenen SM
    Scand J Infect Dis; 1994; 26(5):585-95. PubMed ID: 7855556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.
    Shenep JL; Hughes WT; Roberson PK; Blankenship KR; Baker DK; Meyer WH; Gigliotti F; Sixbey JW; Santana VM; Feldman S
    N Engl J Med; 1988 Oct; 319(16):1053-8. PubMed ID: 3050517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan.
    Khan MA; Siddiqui BK; Shamim A; Yosuf MA; Ahmed U; Zakiullah N; Burney IA
    J Pak Med Assoc; 2004 Jul; 54(7):357-60. PubMed ID: 15449917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotics in febrile neutropenia: a randomized prospective comparison of two combinations.
    Madiajagane R; Maitreyan V; Sagar TG; Shanta V
    Natl Med J India; 1993; 6(2):67-70. PubMed ID: 8477212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer.
    Rubenstein EB; Rolston K; Benjamin RS; Loewy J; Escalante C; Manzullo E; Hughes P; Moreland B; Fender A; Kennedy K
    Cancer; 1993 Jun; 71(11):3640-6. PubMed ID: 8490912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients.
    Bodey G; Abi-Said D; Rolston K; Raad I; Whimbey E
    Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):625-34. PubMed ID: 8894569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients.
    Laszlo D; Bacci S; Bosi A; Fanci R; Guidi S; Saccardi R; Vannucchi AM; Rossi Ferrini P
    J Chemother; 1997 Apr; 9(2):95-101. PubMed ID: 9176746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aztreonam therapy in neutropenic patients with cancer.
    Jones PG; Rolston KV; Fainstein V; Elting L; Walters RS; Bodey GP
    Am J Med; 1986 Aug; 81(2):243-8. PubMed ID: 3526885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomised comparison of ceftazidime and imipenem as initial monotherapy for febrile episodes in neutropenic cancer patients.
    Aparicio J; Oltra A; Llorca C; Montalar J; Herranz C; Gómez-Codina J; Pastor M; Munárriz B
    Eur J Cancer; 1996 Sep; 32A(10):1739-43. PubMed ID: 8983283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone.
    Winston DJ; Ho WG; Bruckner DA; Champlin RE
    Ann Intern Med; 1991 Dec; 115(11):849-59. PubMed ID: 1952471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: microbiological, clinical and economic evaluation.
    D'Antonio D; Staniscia T; Piccolomini R; Fioritoni G; Rotolo S; Parruti G; Di Bonaventura G; Manna A; Savini V; Fiorilli MP; Di Giovanni P; Francione A; Schioppa F; Romano F
    Chemotherapy; 2004 Jun; 50(2):81-7. PubMed ID: 15211082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
    Anaissie EJ; Fainstein V; Bodey GP; Rolston K; Elting L; Kantarjian H; Cabanillas F; McCredie KB
    Am J Med; 1988 Mar; 84(3 Pt 2):581-9. PubMed ID: 3279774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imipenem/cilastatin monotherapy as salvage treatment in febrile neutropenic patients.
    Engervall P; Günther G; Ljungman P; Lönnqvist B; Hast R; Stiernstedt G; Kalin M; Ringertz S; Björkholm M
    J Chemother; 1996 Oct; 8(5):382-6. PubMed ID: 8957719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fever and neutropenia in children with cancer: a new therapeutic proposal].
    Petrilli AS; Melaragno R; Bianchi A; Kusano E; Barros KV; Silva AA
    AMB Rev Assoc Med Bras; 1991; 37(4):173-80. PubMed ID: 1668624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.